Alembic Pharmaceuticals Rating: Buy — A good performance by the company in Q4

India business saw strong growth; FY21/22e EPS up 7.5/7.3%; outlook for US is bright; TP raised to Rs 770.

from The Financial Express https://ift.tt/3eXZfTZ